Selective Agonists of Somatostatin Receptor Subtype 1 or 2 Injected Peripherally Induce Antihyperalgesic Effect in Two Models of Visceral Hypersensitivity in Mice

Peptides - United States
doi 10.1016/j.peptides.2014.10.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Synthesis and Biological Activities of Potent Peptidomimetics Selective for Somatostatin Receptor Subtype 2

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Design of Subtype Selective Melatonin Receptor Agonists and Antagonists

Reproduction Nutrition Development
1999English

WB4101-Related Compounds: New, Subtype-Selective A1-Adrenoreceptor Antagonists (Or Inverse Agonists?)

English

Antihyperalgesic Effect of Tetrodotoxin in Rat Models of Persistent Muscle Pain

Neuroscience
Neuroscience
2015English

Chronic Peripheral Administration of Somatostatin Receptor Subtype-4 Agonist NNC 26-9100 Enhances Learning and Memory in SAMP8 Mice

European Journal of Pharmacology
Pharmacology
2011English

Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice

Journal of Neuroscience
Neuroscience
2015English

The Effect of Two Selective a 1 ‐receptor Agonists and the Bitopic Ligand VCP746 on Heart Rate and Regional Vascular Conductance in Conscious Rats.

British Journal of Pharmacology
Pharmacology
2020English

Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 With Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

Frontiers in Pharmacology
Pharmacology
2017English

Selective V1a Receptor Agonists in Experimental Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy